Compounds > 3-iodopindolol
Page last updated: 2024-09-03

3-iodopindolol and dinoprostone

3-iodopindolol has been researched along with dinoprostone in 1 studies

Compound Research Comparison

Studies
(3-iodopindolol)		Trials
(3-iodopindolol)		Recent Studies (post-2010)
(3-iodopindolol)		Studies
(dinoprostone)		Trials
(dinoprostone)		Recent Studies (post-2010) (dinoprostone)
940029,1051,3466,357

Protein Interaction Comparison

ProteinTaxonomy3-iodopindolol (IC50)dinoprostone (IC50)
Prostaglandin E2 receptor EP1 subtypeHomo sapiens (human)0.0155
Prostaglandin E2 receptor EP4 subtypeHomo sapiens (human)0.0031
Prostaglandin E2 receptor EP4 subtypeRattus norvegicus (Norway rat)0.0021
Prostaglandin E2 receptor EP3 subtypeHomo sapiens (human)0.002
Prostaglandin E2 receptor EP2 subtypeHomo sapiens (human)0.0087
Prostacyclin receptorHomo sapiens (human)0.26
Prostaglandin E2 receptor EP2 subtypeRattus norvegicus (Norway rat)0.0052

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, PL; Maguire, ME; Moore, JJ; Moore, RM; Roberts, JM; Zink, E1

Other Studies

1 other study(ies) available for 3-iodopindolol and dinoprostone

ArticleYear
Ritodrine: a beta-adrenergic receptor antagonist in human amnion.
    American journal of obstetrics and gynecology, 1993, Volume: 168, Issue:1 Pt 1

    Topics: Amnion; Binding, Competitive; Cyclic AMP; Dinoprostone; Epinephrine; Humans; Isoproterenol; Norepinephrine; Pindolol; Receptors, Adrenergic, beta; Ritodrine

1993